




Searching News Database: rosacea
HSMN NewsFeed - 8 Sep 2020
Menlo Therapeutics Announces Completion of Corporate Name Change to VYNE Therapeutics
Menlo Therapeutics Announces Completion of Corporate Name Change to VYNE Therapeutics
HSMN NewsFeed - 4 Jun 2018
AOBiome Therapeutics Announces Election of Dr. Jun Wang as Chairman of the Board of Directors
AOBiome Therapeutics Announces Election of Dr. Jun Wang as Chairman of the Board of Directors
HSMN NewsFeed - 24 May 2016
Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%
Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%
HSMN NewsFeed - 11 Jan 2016
Galderma Laboratories, L.P. Appoints Miles Harrison as Leader of U.S. and Canada
Galderma Laboratories, L.P. Appoints Miles Harrison as Leader of U.S. and Canada
HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
HSMN NewsFeed - 30 Dec 2013
FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid
FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid
HSMN NewsFeed - 12 Dec 2012
Galderma, World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig
Galderma, World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig
HSMN NewsFeed - 10 Apr 2012
Ellman International, Inc. Appoints Dave Pfeiffer as Chief Commercial Officer
Ellman International, Inc. Appoints Dave Pfeiffer as Chief Commercial Officer
HSMN NewsFeed - 28 Sep 2011
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
HSMN NewsFeed - 19 Jul 2011
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
HSMN NewsFeed - 21 Sep 2009
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
HSMN NewsFeed - 26 Jun 2009
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
HSMN NewsFeed - 18 Jun 2009
Studies Highlight A Revolutionary New Method of Treating Post-Operative Bruising
Studies Highlight A Revolutionary New Method of Treating Post-Operative Bruising
HSMN NewsFeed - 31 Mar 2009
AZZALURE( )is Approved in France for Aesthetic Use in the Treatment of Frown Lines
AZZALURE( )is Approved in France for Aesthetic Use in the Treatment of Frown Lines
HSMN NewsFeed - 12 Mar 2009
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
HSMN NewsFeed - 5 Mar 2009
Pyratine XR(TM) Launches at 67th AAD Meeting, Offering Hope to 14 Million Rosacea Sufferers
Pyratine XR(TM) Launches at 67th AAD Meeting, Offering Hope to 14 Million Rosacea Sufferers
HSMN NewsFeed - 29 Jul 2008
European Commission Grants Marketing Authorization for MediGene's Drug Oracea
European Commission Grants Marketing Authorization for MediGene's Drug Oracea
HSMN NewsFeed - 7 Mar 2008
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
HSMN NewsFeed - 26 Feb 2008
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
HSMN NewsFeed - 28 Jun 2007
Bradley Pharmaceuticals Launches Kerol(TM) Topical Suspension and ROSULA(R) Clarifying Wash(TM)
Bradley Pharmaceuticals Launches Kerol(TM) Topical Suspension and ROSULA(R) Clarifying Wash(TM)
HSMN NewsFeed - 23 Apr 2007
CollaGenex Pharmaceuticals Provides Update on Examination of Incyclinide Patent Application
CollaGenex Pharmaceuticals Provides Update on Examination of Incyclinide Patent Application
HSMN NewsFeed - 4 Apr 2007
Vbeam(R) Laser Provides Safe and Effective Treatment for Debilitating Skin Disorder
Vbeam(R) Laser Provides Safe and Effective Treatment for Debilitating Skin Disorder
HSMN NewsFeed - 5 Oct 2006
New Non-Invasive Applications for LED Light Therapy From Photo Therapeutics
New Non-Invasive Applications for LED Light Therapy From Photo Therapeutics
HSMN NewsFeed - 21 Jun 2006
DUSA Pharmaceuticals Announces Georgia Court Dismissal of River's Edge Suit
DUSA Pharmaceuticals Announces Georgia Court Dismissal of River's Edge Suit
HSMN NewsFeed - 15 May 2006
Dusa Pharmaceuticals Announces Court Ruling Halts Sale of Generic Nicomide'R'
Dusa Pharmaceuticals Announces Court Ruling Halts Sale of Generic Nicomide'R'
HSMN NewsFeed - 8 May 2006
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Additional items found! 72

Members Archive contains
72 additional stories matching:
rosacea
(Password required)
rosacea
(Password required)